Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers
This study has been terminated.
( Study terminated due to treatment-emergent serious adverse events )
Study NCT00870441   Information provided by Astellas Pharma Inc

First Received on March 25, 2009.   Last Updated on February 27, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Safety of ASP2151
Interventions listed in this trial
ASP2151
Valacyclovir
Placebo
Additional drug interventions recognized in this trial
Acyclovir
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services